P. Gorry

发表

Futuristic Methods for Determining HIV Co-receptor Use

J. Flynn, Matthew J. Gartner, Annamarie E. Laumaea, 2019, Global Virology III: Virology in the 21st Century.

Molecular Gymnastics: Mechanisms of HIV-1 Resistance to CCR5 Antagonists and Impact on Virus Phenotypes.

M. Churchill, S. Lewin, J. Flynn, 2015, Current topics in medicinal chemistry.

Differences in coreceptor specificity contribute to alternative tropism of HIV-1 subtype C for CD4+ T-cell subsets, including stem cell memory T-cells

M. Churchill, J. Flynn, P. Gorry, 2014, Retrovirology.

Macrophage Tropism of Human Immunodeficiency Virus Type 1 Isolates from Brain and Lymphoid Tissues Predicts Neurotropism Independent of Coreceptor Specificity

E. De Clercq, Steven Wolinsky, K. Kunstman, 2001, Journal of Virology.

Regulation of CC chemokine receptor 5 and CD4 expression and human immunodeficiency virus type 1 replication in human macrophages and microglia by T helper type 2 cytokines.

P. Gorry, Jianbin Wang, K. Crawford, 2002, The Journal of infectious diseases.

Pathogenesis of macrophage tropic HIV-1.

M. Churchill, P. Gorry, A. Cunningham, 2005, Current HIV research.

Asn 362 in gp120 contributes to enhanced fusogenicity by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with AIDS

M. Churchill, D. Purcell, S. Wesselingh, 2007, Retrovirology.

Increased CCR5 Affinity and Reduced CCR5/CD4 Dependence of a Neurovirulent Primary Human Immunodeficiency Virus Type 1 Isolate

John P. Moore, Steven Wolinsky, K. Kunstman, 2002, Journal of Virology.

T Cells: The Role of Langerin Transfer from Primary Langerhans Cells to Inhibition of Two Temporal Phases of HIV-1

P. Gorry, A. Cunningham, S. Turville, 2014 .

Inhibition of Two Temporal Phases of HIV-1 Transfer from Primary Langerhans Cells to T Cells: The Role of Langerin

R. Center, P. Gorry, N. Nasr, 2014, The Journal of Immunology.

Apoptosis of Bystander T Cells Induced by Human Immunodeficiency Virus Type 1 with Increased Envelope/Receptor Affinity and Coreceptor Binding Site Exposure

E. De Clercq, P. Gorry, K. Peden, 2004, Journal of Virology.

Flow Cytometry Analysis to Identify Human CD8+ T Cells.

J. Flynn, P. Gorry, 2019, Methods in molecular biology.

Flow Cytometry Analysis to Identify Human CD4+ T Cell Subsets.

J. Flynn, P. Gorry, 2019, Methods in molecular biology.

Quantifying Susceptibility of CD4+ Stem Memory T-Cells to Infection by Laboratory Adapted and Clinical HIV-1 Strains

M. Churchill, J. Flynn, P. Gorry, 2014, Viruses.

RNASeq analysis of Aedes albopictus mosquitoes during chikungunya virus infection

P. Gorry, Prasad N. Paradkar, J. Duchemin, 2018, bioRxiv.

Frequency and Env determinants of HIV-1 subtype C strains from antiretroviral therapy-naive subjects that display incomplete inhibition by maraviroc

M. Churchill, J. Flynn, P. Gorry, 2016, Retrovirology.

Site-Selective Solid-Phase Synthesis of a CCR5 Sulfopeptide Library To Interrogate HIV Binding and Entry

R. Payne, M. Stone, P. Gorry, 2014, ACS chemical biology.

Advances in measuring apoptosis: A robust, highly sensitive and specific qPCR-based protocol for absolute quantitation of apoptotic DNA

P. Gorry, C. Cherry, L. Gray, 2013 .

Measuring and monitoring apoptosis and drug toxicity in HIV patients by ligation-mediated polymerase chain reaction

S. Wesselingh, P. Gorry, C. Cherry, 2008, Journal of cellular and molecular medicine.

CXCR4-Using HIV Strains Predominate in Naive and Central Memory CD4+ T Cells in People Living with HIV on Antiretroviral Therapy: Implications for How Latency Is Established and Maintained

M. Churchill, S. Lewin, Matthew J. Gartner, 2019, Journal of Virology.

Evolution of DC-SIGN use revealed by fitness studies of R5 HIV-1 variants emerging during AIDS progression

M. Churchill, D. Purcell, J. Albert, 2008, Retrovirology.

Coreceptors and HIV-1 Pathogenesis

P. Gorry, P. Ancuta, P. Ancuța, 2011, Current HIV/AIDS reports.

CD4 and MHC class 1 down-modulation activities of nef alleles from brain- and lymphoid tissue-derived primary HIV-1 isolates

M. Churchill, S. Wesselingh, P. Gorry, 2011, Journal of NeuroVirology.

The magnitude of HIV-1 resistance to the CCR5 antagonist maraviroc may impart a differential alteration in HIV-1 tropism for macrophages and T-cell subsets.

M. Churchill, S. Lewin, D. Purcell, 2013, Virology.

Persistence of attenuated HIV-1 rev alleles in an epidemiologically linked cohort of long-term survivors infected with nef-deleted virus

M. Churchill, S. Wesselingh, P. Gorry, 2007 .

Genetic and Functional Analysis of R5X4 Human Immunodeficiency Virus Type 1 Envelope Glycoproteins Derived from Two Individuals Homozygous for the CCR5Δ32 Allele

M. Churchill, D. Purcell, S. Wesselingh, 2006, Journal of Virology.

Specificity Neurotropism Independent of Coreceptor from Brain and Lymphoid Tissues Predicts Immunodeficiency Virus Type 1 Isolates Macrophage Tropism of Human

Kimberly, K. Kunstman, R. Swanstrom, 2001 .

Enhanced CD4+ cellular apoptosis by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with progressive HIV-1 infection.

M. Churchill, D. Purcell, N. Saksena, 2010, Virology.

Tissue-Specific Sequence Alterations in the Human Immunodeficiency Virus Type 1 Envelope Favoring CCR5 Usage Contribute to Persistence of Dual-Tropic Virus in the Brain

M. Churchill, D. Purcell, S. Wesselingh, 2009, Journal of Virology.

Apoptosis induced in synchronized human immunodeficiency virus type 1-infected primary peripheral blood mononuclear cells is detected after the peak of CD4+ T-lymphocyte loss and is dependent on the tropism of the gp120 envelope glycoprotein.

D. Purcell, A. Greenway, D. McPhee, 2004, Virology.

Novel pathway of human immunodeficiency virus type 1 uptake and release in astrocytes.

J. N. Clarke, S. Wesselingh, P. Gorry, 2006, Virology.

HIV-1 and SIV Predominantly Use CCR5 Expressed on a Precursor Population to Establish Infection in T Follicular Helper Cells

B. Autran, D. Cooper, S. Alcântara, 2017, Front. Immunol..

ExVivo Response to Histone Deacetylase (HDAC) Inhibitors of the HIV Long Terminal Repeat (LTR) Derived from HIV-Infected Patients on Antiretroviral Therapy

M. Churchill, S. Lewin, S. Wesselingh, 2014 .

Both CD31(+) and CD31⁻ naive CD4(+) T cells are persistent HIV type 1-infected reservoirs in individuals receiving antiretroviral therapy.

S. Lewin, N. Saksena, P. Gorry, 2010, The Journal of infectious diseases.

CXCR4 or CCR5 tropism of human immunodeficiency virus type 1 isolates does not determine the immunological milieu in patients responding to antiretroviral therapy.

P. Price, P. Gorry, Silvia Lee, 2006, Viral immunology.

Genotypic Prediction of Co-receptor Tropism of HIV-1 Subtypes A and C

Dominik Heider, Rolf Kaiser, Bettina Budeus, 2016, Scientific Reports.

HIV-1 Escape from the CCR5 Antagonist Maraviroc Associated with an Altered and Less-Efficient Mechanism of gp120-CCR5 Engagement That Attenuates Macrophage Tropism

M. Churchill, S. Lewin, P. Gorry, 2011, Journal of Virology.

A common mechanism of clinical HIV-1 resistance to the CCR5 antagonist maraviroc despite divergent resistance levels and lack of common gp120 resistance mutations

Brendan L Wilkinson, M. Churchill, S. Lewin, 2013, Retrovirology.

Alternative Coreceptor Requirements for Efficient CCR5- and CXCR4-Mediated HIV-1 Entry into Macrophages

Paul A. Ramsland, M. Churchill, P. Gorry, 2011, Journal of Virology.

Changes in the V3 region of gp120 contribute to unusually broad coreceptor usage of an HIV-1 isolate from a CCR5 Delta32 heterozygote.

John R Mascola, Tom Morgan, J. Mascola, 2007, Virology.

Highly active antiretroviral therapy and human immunodeficiency virus encephalitis

S. Wesselingh, P. Gorry, W. Tyor, 2005, Annals of neurology.

Enhanced Replicative Capacity and Pathogenicity of HIV-1 Isolated From Individuals Infected With Drug-Resistant Virus and Declining CD4+ T-Cell Counts

S. Lewin, P. Gorry, N. Lane, 2005, Journal of acquired immune deficiency syndromes.

Virucidal activity of the dendrimer microbicide SPL7013 against HIV-1.

P. Gorry, P. Ramsland, J. Paull, 2011, Antiviral research.

Structure Activity Relationship of Dendrimer Microbicides with Dual Action Antiviral Activity

S. Wesselingh, Mark Zanin, P. Gorry, 2010, PloS one.

Possible clearance of transfusion-acquired nef/LTR-deleted attenuated HIV-1 infection by an elite controller with CCR5 Δ32 heterozygous and HLA-B57 genotype

M. Churchill, D. Cooper, A. Kelleher, 2019, Journal of virus eradication.

DExD/H-box helicases in HIV-1 replication and their inhibition.

N. Borg, P. Gorry, Steven M Heaton, 2022, Trends in microbiology.

RNASeq Analysis of Aedes albopictus Mosquito Midguts after Chikungunya Virus Infection

P. Gorry, Prasad N. Paradkar, J. Duchemin, 2019, Viruses.

CD4-binding site alterations in CCR5-using HIV-1 envelopes influencing gp120-CD4 interactions and fusogenicity.

M. Churchill, S. Wesselingh, P. Gorry, 2011, Virology.

Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo

M. Churchill, S. Lewin, S. Wesselingh, 2007, Retrovirology.

The CD16+ Monocyte Subset Is More Permissive to Infection and Preferentially Harbors HIV-1 In Vivo1

W. Greene, S. Lewin, P. Gorry, 2007, The Journal of Immunology.

The CD 16 Monocyte Subset Is More Permissive to Infection and Preferentially Harbors HIV-1 In Vivo 1

W. Greene, S. Lewin, P. Gorry, 2007 .

Impaired complement-mediated phagocytosis by HIV type-1-infected human monocyte-derived macrophages involves a cAMP-dependent mechanism.

Daniel Doischer, K. Kedzierska, P. Gorry, 2006, AIDS research and human retroviruses.

Envelope glycoprotein determinants of increased entry in a pathogenic simian-human immunodeficiency virus (SHIV-HXBc2P 3.2) passaged in monkeys.

C. M. Owens, J. Sodroski, P. Gorry, 2004, AIDS research and human retroviruses.

A new way of measuring apoptosis by absolute quantitation of inter-nucleosomally fragmented genomic DNA

S. Lewin, P. Gorry, R. Rajasuriar, 2012, Nucleic acids research.

Diminished Production of Human Immunodeficiency Virus Type 1 in Astrocytes Results from Inefficient Translation ofgag, env, and nef mRNAs despite Efficient Expression of Tat and Rev

M. Churchill, J. Howard, D. Purcell, 1999, Journal of Virology.

Potential Impact of Human Cytomegalovirus Infection on Immunity to Ovarian Tumours and Cancer Progression

P. Gorry, M. Plebanski, A. Kartikasari, 2021, Biomedicines.

A novel, rapid method to detect infectious HIV-1 from plasma of persons infected with HIV-1.

S. Lewin, P. Gorry, S. Crowe, 2010, Journal of virological methods.

Longitudinal Analysis of Human Immunodeficiency Virus Type 1 nef/Long Terminal Repeat Sequences in a Cohort of Long-Term Survivors Infected from a Single Source

M. Churchill, S. Wesselingh, P. Gorry, 2006, Journal of Virology.

The HIV Env variant N283 enhances macrophage tropism and is associated with brain infection and dementia

Steven Wolinsky, K. Kunstman, P. Gorry, 2006, Proceedings of the National Academy of Sciences.

Genetic and Functional Analysis of Full-Length Human Immunodeficiency Virus Type 1 env Genes Derived from Brain and Blood of Patients with AIDS

B. Korber, Steven Wolinsky, K. Kunstman, 2003, Journal of Virology.

Role of Macrophages in the Immunopathogenesis of HIV-1 Infection

J. Flynn, P. Gorry, Jacqueline K. Flynn, 2015 .

Macrophage‐tropic HIV‐1 variants from brain demonstrate alterations in the way gp120 engages both CD4 and CCR5

M. Churchill, P. Gorry, N. Webb, 2013, Journal of leukocyte biology.

An altered and more efficient mechanism of CCR5 engagement contributes to macrophage tropism of CCR5-using HIV-1 envelopes.

M. Churchill, S. Wesselingh, P. Gorry, 2010, Virology.

Viral tropism, fitness and pathogenicity of HIV-1 subtype C

M. Churchill, P. Gorry, M. Jakobsen, 2010 .

Uncoupling coreceptor usage of human immunodeficiency virus type 1 (HIV-1) from macrophage tropism reveals biological properties of CCR5-restricted HIV-1 isolates from patients with acquired immunodeficiency syndrome.

Steven L Wesselingh, Anthony L Cunningham, Lachlan Gray, 2005, Virology.

The role of viral coreceptors and enhanced macrophage tropism in human immunodeficiency virus type 1 disease progression.

M. Churchill, S. Wesselingh, P. Gorry, 2004, Sexual health.

Stem memory T cells (TSCM)—their role in cancer and HIV immunotherapies

J. Flynn, P. Gorry, Jacqueline K. Flynn, 2014, Clinical & translational immunology.

Understanding the mechanisms driving the spread of subtype C HIV-1

M. Churchill, J. Flynn, Matthew J. Gartner, 2020, EBioMedicine.

Extremely prolonged HIV seroconversion associated with an MHC haplotype carrying disease susceptibility genes for antibody deficiency disorders.

S. Lewin, D. McPhee, P. Gorry, 2010, Clinical immunology.

High Viral Fitness during Acute HIV-1 Infection

A. Kelleher, M. Law, D. McPhee, 2010, PloS one.

Persistence of envelopes in different CD4+ T-cell subsets in antiretroviral therapy-suppressed people with HIV

M. Churchill, S. Lewin, J. Flynn, 2022, AIDS.

Ex Vivo Response to Histone Deacetylase (HDAC) Inhibitors of the HIV Long Terminal Repeat (LTR) Derived from HIV-Infected Patients on Antiretroviral Therapy

M. Churchill, S. Lewin, S. Wesselingh, 2014, PloS one.

Distinct HIV-1 entry phenotypes are associated with transmission, subtype specificity, and resistance to broadly neutralizing antibodies

T. Chou, P. Gorry, N. Webb, 2014, Retrovirology.

Structural elements of primary CCR5-using HIV-1 gp120 proteins influencing sensitivity and resistance to the broadly neutralizing monoclonal antibody b12.

M. Churchill, S. Wesselingh, P. Gorry, 2012, Virology.

Low levels of HIV-1 envelope-mediated fusion are associated with long-term survival of an infected CCR5−/− patient

P. Gorry, J. Mohl, Fahim Ahmad, 2018, AIDS.

Transcriptional activity of blood- and cerebrospinal fluid-derived nef/long-terminal repeat sequences isolated from a slow progressor infected with nef-deleted human immunodeficiency virus type 1 (HIV-1) who developed HIV-associated dementia

M. Churchill, D. Purcell, S. Wesselingh, 2006, Journal of NeuroVirology.

Mechanisms of HIV non-progression; robust and sustained CD4+ T-cell proliferative responses to p24 antigen correlate with control of viraemia and lack of disease progression after long-term transfusion-acquired HIV-1 infection

J. Zaunders, N. Saksena, D. McPhee, 2008, Retrovirology.

Replication-Dependent Pathogenicity of Attenuated nef-Deleted HIV-1 In Vivo

M. Churchill, S. Wesselingh, P. Gorry, 2007, Journal of acquired immune deficiency syndromes.

Phenotype and envelope gene diversity of nef-deleted HIV-1 isolated from long-term survivors infected from a single source

M. Churchill, S. Wesselingh, D. McPhee, 2007, Virology Journal.

Macrophage Tropism and Cytopathicity of HIV-1 Variants Isolated Sequentially from a Long-Term Survivor Infected with nef-Deleted Virus

M. Churchill, S. Wesselingh, D. McPhee, 2007, The open microbiology journal.

Viral Phenotypes and Antibody Responses in Long-Term Survivors Infected with Attenuated Human Immunodeficiency Virus Type 1 Containing Deletions in the nef and Long Terminal Repeat Regions

M. Churchill, S. Wesselingh, D. McPhee, 2007, Journal of Virology.

Changes in the V 3 region of gp 120 contribute to unusually broad coreceptor usage of an HIV-1 isolate from a CCR 5 Delta 32 heterozygote

Steven M. Wolinsky, John R. Mascola, Tom Morgan, 2007 .

In vivo replication kinetics of a nef-deleted strain of HIV-1.

D. Ho, B. Brew, J. Mills, 2005, AIDS.

Longitudinal analysis of nef/long terminal repeat-deleted HIV-1 in blood and cerebrospinal fluid of a long-term survivor who developed HIV-associated dementia.

M. Churchill, S. Wesselingh, B. Brew, 2004, The Journal of infectious diseases.

Extensive astrocyte infection is prominent in human immunodeficiency virus–associated dementia

M. Churchill, S. Wesselingh, B. Brew, 2009, Annals of neurology.

Astrocyte specific viral strains in HIV dementia

M. Churchill, S. Wesselingh, P. Gorry, 2004, Annals of neurology.

HIV-1 transcriptional regulation in the central nervous system and implications for HIV cure research

M. Churchill, S. Wesselingh, P. Gorry, 2014, Journal of NeuroVirology.

Astrocyte infection by HIV-1: mechanisms of restricted virus replication, and role in the pathogenesis of HIV-1-associated dementia.

D. Purcell, P. Gorry, A. Gatignol, 2003, Current HIV research.

Primary HIV-1 R5 isolates from end-stage disease display enhanced viral fitness in parallel with increased gp120 net charge.

M. Churchill, D. Purcell, J. Albert, 2008, Virology.

Chapter 5.3 – HIV-1-Associated Dementia

P. Gorry, Jianbin Wang, Jianbin Wang, 2002 .

Longitudinal analysis of subtype C envelope tropism for memory CD4+ T cell subsets over the first 3 years of untreated HIV-1 infection

M. Churchill, S. Lewin, P. Moore, 2020, Retrovirology.

i-bodies, Human Single Domain Antibodies That Antagonize Chemokine Receptor CXCR4*

Olan Dolezal, Kathy Parisi, Joanne L Casey, 2016, The Journal of Biological Chemistry.

Intact HIV Proviruses Persist in the Brain Despite Viral Suppression with ART

M. Churchill, S. Lewin, B. Brew, 2022, Annals of neurology.

HIV-1 Entry and Trans-Infection of Astrocytes Involves CD81 Vesicles

M. Churchill, S. Wesselingh, P. Gorry, 2014, PloS one.

Low TRBP Levels Support an Innate Human Immunodeficiency Virus Type 1 Resistance in Astrocytes by Enhancing the PKR Antiviral Response

J. Howard, D. Purcell, P. Gorry, 2005, Journal of Virology.

Restricted HIV-1 infection of human astrocytes: potential role of nef in the regulation of virus replication.

J. Howard, D. Purcell, D. McPhee, 1998, Journal of neurovirology.

Is the central nervous system a reservoir of HIV-1?

M. Churchill, S. Wesselingh, J. Flynn, 2014, Current opinion in HIV and AIDS.

CNS-specific regulatory elements in brain-derived HIV-1 strains affect responses to latency-reversing agents with implications for cure strategies

M. Churchill, S. Lewin, S. Wesselingh, 2015, Molecular Psychiatry.

Modular Lentiviral Vectors for Highly Efficient Transgene Expression in Resting Immune Cells

M. Churchill, P. Gorry, S. Turville, 2021, Viruses.

Inhibition of catechol-O-methyl transferase (COMT) by tolcapone restores reductions in microtubule-associated protein 2 (MAP2) and synaptophysin (SYP) following exposure of neuronal cells to neurotropic HIV

M. Churchill, I. Everall, P. Gorry, 2015, Journal of NeuroVirology.

Bioinformatic prediction programs underestimate the frequency of CXCR4 usage by R5X4 HIV type 1 in brain and other tissues.

Steven Wolinsky, K. Kunstman, P. Gorry, 2008, AIDS research and human retroviruses.

Professor Mark Wainberg

B. Berkhout, P. Borrow, A. Fassati, 2017, Retrovirology.

The NRTIs Lamivudine, Stavudine and Zidovudine Have Reduced HIV-1 Inhibitory Activity in Astrocytes

M. Churchill, S. Wesselingh, B. Brew, 2013, PloS one.

Genetic and functional heterogeneity of CNS-derived tat alleles from patients with HIV-associated dementia

M. Churchill, S. Wesselingh, P. Gorry, 2011, Journal of NeuroVirology.

Whole Transcriptome Analysis of Aedes albopictus Mosquito Head and Thorax Post-Chikungunya Virus Infection

P. Gorry, Prasad N. Paradkar, J. Duchemin, 2019, Pathogens.

Transmission of HIV-1 drug-resistant variants: prevalence and effect on treatment outcome.

P. Gorry, M. Tolstrup, M. Jakobsen, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

V3 determinants of HIV-1 escape from the CCR5 inhibitors Maraviroc and Vicriviroc.

John P. Moore, R. Berro, R. Sanders, 2012, Virology.

Constrained use of CCR5 on CD4+ lymphocytes by R5X4 HIV-1: efficiency of Env-CCR5 interactions and low CCR5 expression determine a range of restricted CCR5-mediated entry.

P. Gorry, Benhur Lee, R. Collman, 2010, Virology.

Increased Sensitivity to Broadly Neutralizing Antibodies of End-Stage Disease R5 HIV-1 Correlates with Evolution in Env Glycosylation and Charge

M. Churchill, J. Albert, E. Fenyö, 2011, PloS one.

HIV‐1 envelope–receptor interactions required for macrophage infection and implications for current HIV‐1 cure strategies

S. Lewin, P. Gorry, R. Collman, 2014, Journal of leukocyte biology.

Use of laser capture microdissection to detect integrated HIV-1 DNA in macrophages and astrocytes from autopsy brain tissues

M. Churchill, D. Purcell, S. Wesselingh, 2006, Journal of NeuroVirology.

Toxicity and in vitro activity of HIV-1 latency-reversing agents in primary CNS cells

M. Churchill, S. Lewin, D. Purcell, 2016, Journal of NeuroVirology.

HIV-1 transcriptional regulation in the central nervous system and implications for HIV cure research

M. Churchill, S. Wesselingh, P. Gorry, 2015, Journal of NeuroVirology.

Understanding mechanisms of HIV-1 entry into cells

P. Gorry, 2014 .

Reduced basal transcriptional activity of central nervous system-derived HIV type 1 long terminal repeats.

M. Churchill, S. Wesselingh, E. Crespan, 2012, AIDS research and human retroviruses.

Conformational alterations in the CD4 binding cavity of HIV-1 gp120 influencing gp120-CD4 interactions and fusogenicity of HIV-1 envelopes derived from brain and other tissues

M. Churchill, P. Gorry, P. Ramsland, 2011, Retrovirology.

Is there a role for plant‐made vaccines in the prevention of HIV/AIDS?

S. Wesselingh, P. Gorry, I. Dry, 2005, Immunology and cell biology.

Analysis of Clinical HIV-1 Strains with Resistance to Maraviroc Reveals Strain-Specific Resistance Mutations, Variable Degrees of Resistance, and Minimal Cross-Resistance to Other CCR5 Antagonists.

M. Churchill, S. Lewin, J. Flynn, 2017, AIDS research and human retroviruses.

Mechanisms of HIV-1 neurotropism.

P. Gorry, Jianbin Wang, E. Thomas, 2006, Current HIV research.

Analysis and dissociation of anti‐HIV effects of shRNA to CCR5 and the fusion inhibitor C46

P. Gorry, S. Turville, J. Murray, 2018, The journal of gene medicine.

Reliable Genotypic Tropism Tests for the Major HIV-1 Subtypes

P. Harrigan, M. Churchill, P. Gorry, 2015, Scientific Reports.

Frequency and Env determinants of HIV-1 subtype C strains from antiretroviral therapy-naive subjects that display incomplete inhibition by maraviroc

M. Churchill, J. Flynn, P. Gorry, 2016, Retrovirology.

Affinofile profiling: how efficiency of CD4/CCR5 usage impacts the biological and pathogenic phenotype of HIV.

T. Chou, P. Gorry, Benhur Lee, 2013, Virology.

Longitudinal Analysis of CCR5 and CXCR4 Usage in a Cohort of Antiretroviral Therapy-Naïve Subjects with Progressive HIV-1 Subtype C Infection

H. Ullum, M. Churchill, D. Purcell, 2013, PloS one.

Persistence of dual-tropic HIV-1 in an individual homozygous for the CCR5Δ32 allele

Chengsheng Zhang, Sam Wu, Steven Wolinsky, 2002, The Lancet.

Persistence of dual-tropic HIV-1 in an individual homozygous for the CCR5 Delta 32 allele.

J. Phair, Steven Wolinsky, K. Kunstman, 2002, Lancet.

Genetic and functional analysis of R5X4 human immunodeficiency virus type 1 envelope glycoproteins derived from two individuals homozygous for the CCR5delta32 allele.

M. Churchill, D. Purcell, S. Wesselingh, 2006, Journal of virology.

Designer antigens for elicitation of broadly neutralizing antibodies against HIV

M. Churchill, P. Gorry, T. Kok, 2014, Clinical & translational immunology.

Covariance of Charged Amino Acids at Positions 322 and 440 of HIV-1 Env Contributes to Coreceptor Specificity of Subtype B Viruses, and Can Be Used to Improve the Performance of V3 Sequence-Based Coreceptor Usage Prediction Algorithms

M. Churchill, P. Gorry, P. Ramsland, 2014, PloS one.

CoRSeqV3-C: a novel HIV-1 subtype C specific V3 sequence based coreceptor usage prediction algorithm

M. Churchill, P. Gorry, M. Jakobsen, 2013, Retrovirology.

Regional Analysis of Intact and Defective HIV Proviruses in the Brain of Viremic and Virally Suppressed People with HIV

M. Churchill, S. Lewin, B. Brew, 2023, Annals of neurology.

HIV-1 predisposed to acquiring resistance to maraviroc (MVC) and other CCR5 antagonists in vitro has an inherent, low-level ability to utilize MVC-bound CCR5 for entry

M. Churchill, S. Lewin, P. Gorry, 2011, Retrovirology.

Explorer Changes in the V 3 region of gp 120 contribute to unusually broad coreceptor usage of an HIV-1 isolate from a CCR 5 Delta 32 heterozygote

J. Mascola, John P. Moore, Steven Wolinsky, 2017 .

T cell therapies-are T memory stem cells the answer?

P. Gorry, Jacqueline K. Flynn, 2015, Annals of translational medicine.